FDA extends Ascendis' TransCon CNP review to Feb. 28, 2026, after new data submission related to post-marketing study ...

Ask the children. Chances are, I reckon, they’ll say Washington and Jefferson ought to have known better than to enslave people. And chances are, an adult ...

Cassidy* stood at the balcony peeping down through the glass, hopping from one foot to the other excitedly, waiting for her uncle to pick her up for their Sunday afternoon adventure. Her mum, Vera*, ...

The island of Flores has guarded one of science’s greatest mysteries: could it be that the Flores man did not actually die out completely?

Long-necked titanosaur skeletons have become some of the most recognisable dinosaurs on Earth, and their presence in ...

In the study, which was published by Nature Communications, the brain evolves in five broad phases throughout our lives, ...

The FDA has delayed a decision on Ascendis Pharma’s dwarfism drug candidate TransCon CNP, pushing back the deadline by three ...

The U.S. Food and Drug Administration on Tuesday extended its review of Ascendis Pharma's therapy for children with a rare ...

The percentage of adults in the United States reporting cognitive disabilities increased between 2013 and 2023, driven by disproportionate growth among those aged 18 to 39 years, according to a study ...

A new study finds that brain changes are not a steady progression; instead, distinct neural rewiring occurs around ages 9, 32 ...

A controlled feeding study out of South Dakota State University shows that older adults who ate fewer ultra-processed foods naturally consumed fewer calories, lost weight and abdominal fat, and showed ...

Itvisma, an intrathecal version of Zolgensma, can be used in children, teens and adults to stabilize or improve motor ...